The global motion sickness drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Motion sickness is a common disorder characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while travelling due to differences in impulses in the eyes, other body tissues, and sensory receptors. Motion sickness is most commonly observed among children and geriatrics. It is experienced by about 50% to 70% of travellers and even while playing virtual reality (VR) games. The pivotal factors that are driving the market growth include a rise in the number of travellers across the globe and increased incidences of CVD in the geriatric population which majorly cause motion sickness.
For instance, as per the United Nations World Tourism Organization (UNWTO), international tourist arrivals increased by 5.4% in 2018 compared to 2017, and this tendency is expected to continue during the forecast period which demands higher requirements for motion sickness treatment globally. Also, ongoing research activities in motion sickness drug development and delivery systems are likely to increase the availability of OTC drugs for motion sickness treatment. Furthermore, some key players operating in the market include Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corp., and CVS Health Corp., among others.
Market Coverage
Competitive Landscape: Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corp., and CVS Health Corp., among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Motion Sickness Drugs Market by Segment
By Treatment Type
• Anticholinergics
• Antihistamines
• Others
By Distribution Channel
• Retail Pharmacies
• Online Pharmacies
• Others
Global Motion Sickness Drugs Market by Region
North America
Europe
Asia-Pacific
Rest of the World